As at 10:55 AM on 8/9/2010
The Share Price is: 27.50 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
£450k raised for further development of the Phase Focus Virtual Lens
17 Jul 2009
Director's Share Purchase
13 Jul 2009
Fusion IP Board Change
09 Jun 2009
£1 Million Co-investment secures development of green communication Technology in Wales
02 Jun 2009
Simcyp enhances flagship simulator in line with pharmaceutical industry priorities.
06 May 2009
Interim Results for the period ended 31st Jan 2009
24 Apr 2009
250k Co-investment secures drug therapy development in wales
01 Apr 2009
Demasq gains FDA approval and appoints new chairman
£350,000 Investment into Adjuvantix
25 Feb 2009
Annual Report and Accounts
27 Jan 2009